Cor Vasa 2023, 65(6):849-854 | DOI: 10.33678/cor.2023.068
(The effect of an inter-atrial communication in the treatment of the patients with heart failure with mildly reduced and preserved ejection fraction - current state of knowledge)
- a Kardiovaskulární centrum, Nemocnice Na Homolce, Praha
- b Mount Sinai Hospital New York, USA
An elevated left atrial pressure at rest and especially at stress is the main cause of symptoms and an increased risk of hospitalization and death in patients with heart failure. The mechanistic approach with implantation of inter-atrial shunt device (IASD) to reduce left atrial pressure in the patients with heart failure with mildly reduced and preserved ejection fraction was feasible and safe in a pilot study. In a non-randomized REDUCE LAP-HF and a randomized REDUCE LAP-HF I study the implantation of IASD was associated with improved symptoms and hemodynamic parameters. The effect of IASD on the risk of cardiovascular events including death and risk of heart failure hospitalizations was the objective of a multicentric randomized sham procedure controlled REDUCE LAP-HF II study. The review article is focused on the rationale of the method and the results of essential studies.
Keywords: Heart failure, Interatrial communication, Left atrial pressure, Scientific evidence
Received: August 9, 2023; Revised: August 9, 2023; Accepted: September 5, 2023; Prepublished online: June 2, 2012; Published: December 22, 2023 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Andersen MJ, Ersboll M, Bro-Jeppesen J, et al. Exercise hemodynamics in patients with and without diastolic dysfunction and preserved ejection fraction after myocardial infarction. Circ Heart Fail 2012;5:444-451.
Go to original source...
Go to PubMed...
- Maeder MT, Thompson BR, Htun N, Kaye DM. Hemodynamic determinants of the abnormal cardiopulmonary exercise response in heart failure with preserved left ventricular ejection fraction. J Card Fail 2012;18:702-710.
Go to original source...
Go to PubMed...
- Holland DJ, Prasad SB, Marwick TH. Prognostic Implications of Left Ventricular Filling Pressure With Exercise. Circ Cardiovasc Imaging 2010;3:149-156.
Go to original source...
Go to PubMed...
- Dorfs S, Zeh W, Hochholzer W, et al. Pulmonary capillary wedge pressure during exercise and long-term mortality in patients with suspected heart failure with preserved ejection fiction. Eur Heart J 2014;35:3103-3112.
Go to original source...
Go to PubMed...
- Lutembacher R. De la stenose mitrale avec communication interauirulaier. Arch Mal Coeur 1916;9:237-260.
- Ewert P, Berger F, Nagdyman N, et al. Masked left ventricular restriction in elderly patients with atrial septal defects: a contraindication for closure? Catheter Cardiovasc Interv 2001;52:177-180.
Go to original source...
- Kaye D, Shah SJ, Borlaug BA, et al. Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure. J Card Fail 2014;20:212-221.
Go to original source...
Go to PubMed...
- Søndergaard L, Reddy V, Kaye D, et al. Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower leftatrial pressure. Eur J Heart Fail 2014;16:796-801.
Go to original source...
Go to PubMed...
- Malek F, Neuzil P, Gustafsson F, et al. Clinical outcome of transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel implant. Int J Cardiol 2015;187:227-228.
Go to original source...
Go to PubMed...
- Hasenfuß, G, Hayward H, Burkhoff D, et al. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet 2016;10025:1298-1304.
Go to original source...
Go to PubMed...
- Kaye DM, Hasenfus G, Neuzil P, et al. One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction. Circ Heart Fail 2016;9:e003662.
Go to original source...
Go to PubMed...
- Dujka L, Neužil P, Reddy V, et al. Long-term follow-up of a patient undergoing interatrial shunt device implantation for treatment of heart failure with a preserved ejection fraction. J Int Med Res 2022;50:1-8.
Go to original source...
Go to PubMed...
- Feldman T, Mauri L, Kahwash R, et al. Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [REDUCE elevated Left Atrial Pressure in patients with Heart Failure]): a phase 2, randomized, sham-controlled trial. Circulation 2018;137:364-375.
Go to original source...
Go to PubMed...
- Shah SJ, Feldman T, Ricciardi MJ, et al. One-year safety and clinical outcomes of a transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction in the REDUCE elevated Left Atrial Pressure in patients with Heart Failure (REDUCE LAP-HF I) trial: a randomized clinical trial. JAMA Cardiol 2018;3:968-977.
Go to original source...
Go to PubMed...
- Berry N, Mauri L, Feldman T, et al. Transcatheter interAtrial shunt device for the treatment of heart failure: rationale and design of the pivotal randomized trial to REDUCE elevated Left Atrial Pressure in patients with Heart Failure II (REDUCE LAP-HF II). Am Heart J 2020;226:222-231.
Go to original source...
Go to PubMed...
- Shah SJ, Borlaug BA, Chung ES, et al. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II):a randomised, multicentre, blinded, sham-controlled trial. Lancet 2022;399:1130-1140.
Go to original source...
Go to PubMed...
- Borlaug BA, Blair J, Bergmann MW, et al.; on behalf of the REDUCE LAP-HF II Investigators. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure. Circulation 2022;45:1592-1604.
Go to original source...
Go to PubMed...
- A study to evaluate the IASD™ System II to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure with reduced ejection fraction. Dostupné z: https://classic.clinicaltrials.gov/ct2/show/study/NCT03093961. Navštíveno: 26. 11. 2023.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.